Navigation Links
Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging,Growth Conference

BOULDER, Colo.--(BUSINESS WIRE)--Jul 5, 2007 - Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Robert E. Conway, will speak at the C.E Unterbeg, Towbin Emerging Growth Conference on July 10 in New York City. The public is welcome to participate in the conference through a webcast on the Array BioPharma website. -0-
Event:          C.E Unterbeg, Towbin Emerging Growth Conference

Presenter:      Robert E. Conway, Chief Executive Officer, Array

                BioPharma

Date:           Tuesday, July 10, 2007

Time:           10:30 a.m. Eastern Time

Location:       Mandarin Oriental Hotel, New York City

Audio Webcast:  www.arraybiopharma.com

About Array BioPharma:

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat life-threatening and debilitating diseases. Our proprietary drug development pipeline is focused on the treatment of cancer and inflammatory disease and includes clinical candidates that are designed to regulate therapeutically important targets. In addition, leading pharmaceutical and biotechnology companies collaborate with Array to discover and develop drug candidates across a broad range of therapeutic areas. For more information on Array, please go to www.arraybiopharma.com.

Contact

Array BioPharma Inc.
Tricia Haugeto, 303-386-1193
thaugeto@arraybiopharma.com


'"/>




Page: 1

Related medicine technology :

1. Array BioPharma Reports New Clinical Data on Its Anti-Inflammatory Drugs
2. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
3. DOR BioPharma Announces Issuance of European Patent for Its Oral Multivalent Botulinum Toxin Vaccine BT-VACC
4. DOR BioPharma Announces Publication Describing Results of Its Multivalent Botulinum Toxin Vaccine BT-VACC
5. PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007 Digestive Disease Week
6. AVI BioPharma Reports Positive Pre-Clinical Influenza Data
7. Helix BioPharma Corp. Announces Positive Phase II Clinical Results with its Topical Interferon Alpha-2b
8. CeNeRx BioPharma Announces Positive Phase I Results in First Human Trial of Third Generation RIMA Antidepressant
9. Integrated BioPharmas Proprietary Vaccine Technology Achieves Strong Positive Results
10. The Past, Present and Future of HLA Typing
11. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2020)... ... April 01, 2020 , ... Dr. Michele S. Green, board-certified ... esteemed Haute Beauty network. , The Haute Beauty Network, well known for its ... Anti-Aging Expert. , Haute Beauty offers a prominent collective of leading doctors nationwide. ...
(Date:4/1/2020)... ... , ... In response to calls for help from healthcare ... to retool their machinery to build N95 masks and ventilators, hospitals are being ... to protect employees from contracting infectious diseases. “We don’t know when these items ...
(Date:3/30/2020)... RESEARCH TRIANGLE PARK, N.C. (PRWEB) , ... March ... ... management and operations, today announced it has been recognized by Dresner Advisory Services ... report recognizes Zaloni for its capabilities related to data orchestration, data transformation, and ...
Breaking Medicine Technology:
(Date:4/5/2020)... ... April 05, 2020 , ... Given the current pandemic and economic crisis, ... essential services. Insurance expenses can rise to several thousand dollars per year. It all ... coverage limits, annual mileage and so on. Drivers can get better rates if they: ...
(Date:4/2/2020)... ... , ... The Northern Virginia Community College Educational Foundation (NOVA Foundation) is proud ... Palm Beach, Florida. Ms. Howe is adding to her existing endowed scholarship fund ... important than ever given the current pandemic. Ms. Howe has also generously donated to ...
(Date:4/1/2020)... ... April 02, 2020 , ... AAGL ... PT/6:00 pm ET- to discuss surgical safety practices in response to the COVID-19 ... State University Healthcare Network in New Orleans and Amsterdam University Medical Center in ...
(Date:4/1/2020)... ... April 01, 2020 , ... American hospital workers ... treating Coronavirus-infected patients. , Staffers are in particular need of face shields, which ... week, The Wall Street Journal reported that New York City mayor Bill de ...
(Date:4/1/2020)... ... 01, 2020 , ... “Medical information is considered to be ... Grover LLP attorney Eric A. Grover. “For that reason, healthcare providers are ... and disclosure of medical information can, under certain circumstances, give rise to claims ...
Breaking Medicine News(10 mins):